DOSSIER · 13F Holders · Q1 2026
COEPW
COEPTIS THERAPEUTICS HLDGS I
5 institutions still hold COEPTIS THERAPEUTICS HLDGS I as of Q1 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 19207A116·5 13F holders·last filed Mar 31, 2026
AI Holders Summary · Q1 2026
5 institutions reported COEPW in Q1 2026. RIVERNORTH CAPITAL MANAGEMENT, LLC leads at 41.8% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.